Many IVF failures and a proportion of birth defects arise because early human embryos often acquire chromosomal abnormalities (aneuploidy and mosaicism) during the very first cell divisions. These errors can come from mistakes in egg meiosis, DNA replication, or mitosis after fertilization — and they explain why a surprisingly large share of embryos created in vitro stop developing within days.
What are the main chromosomal problems?
- Aneuploidy — a whole chromosome is missing or extra (e.g., trisomy 21). Common cause of implantation failure, miscarriage, or congenital defects.
- Mosaicism — the embryo contains a mix of normal (euploid) and abnormal (aneuploid) cells. Mosaic embryos are extremely common by blastocyst stage and have variable outcomes.
- Structural chromosome errors — deletions, duplications, translocations that may be inherited or arise early in development.
When and how do these errors happen?
- Meiotic errors in the oocyte (before or at fertilization) — eggs from older women are more likely to carry missegregated chromosomes (age-related risk). These cause complete aneuploidy in the resulting embryo.
- Faulty DNA replication very early after fertilization — recent work shows spontaneous replication errors in the first mitotic cycles create daughter cells with incorrect chromosome numbers; this is a major contributor to embryo arrest.
- Mitotic spindle/segregation errors during cleavage — chromosome segregation machinery can misroute chromosomes during cell division, producing mosaicism.
- Laboratory / environmental contributors — suboptimal culture, oxidative stress, or handling may increase the chance of errors (research ongoing).
How common is this?
- Single-cell and next-generation sequencing studies report very high rates of mosaicism/aneuploidy at cleavage and blastocyst stages — in some datasets >50–80% of embryos show some aneuploid cells (though often only a minority of cells are abnormal).
Clinical consequences
- Implantation failure — many embryos with widespread aneuploidy cannot implant.
- Early pregnancy loss (miscarriage) — embryo aneuploidy is the leading cause.
- Liveborns with defects — when aneuploid or mosaic embryos implant and continue development, there is an increased risk of congenital abnormalities (depending on which chromosomes/genes are affected).
Can embryos “self-correct”?
- There is evidence embryos can sometimes selectively eliminate aneuploid cells or dilute them during subsequent divisions, a process referred to as self-correction. This explains why some mosaic embryos still lead to healthy births. However, the mechanisms, predictability, and limits of self-correction are active research topics.
Role of Preimplantation Genetic Testing for Aneuploidy (PGT-A)
- PGT-A samples cells from the blastocyst to test for chromosomal abnormalities and can reduce transfer of fully aneuploid embryos.
- Limitations & controversies: PGT-A can detect mosaic results that are hard to interpret; sampling one small part of the embryo may not reflect the whole embryo’s status. Clinical guidance exists for managing mosaic results and counseling patients.
How clinics and patients can reduce risks / improve outcomes
- Optimize maternal health & ovarian reserve earlier (age is the strongest non-modifiable risk).
- Use best-practice lab protocols (time-lapse monitoring, controlled culture conditions, minimize oxidative stress).
- Offer PGT-A with informed counseling about limitations and mosaic outcomes.
- Consider single embryo transfer (SET) to avoid complications from multiple gestation that compound risk.
- Research participation — many clinics contribute to studies aiming to understand and reduce embryo chromosomal errors.
Research directions (what scientists are working on)
- Pinpointing molecular causes of replication/segregation errors in humans.
- Improving non-invasive embryo assessment (spent media, AI image analysis) to detect embryos with stable euploid potential.
- Understanding mechanisms and limits of embryo self-correction and how to safely leverage it clinically.
Bottom line
Chromosomal abnormalities—arising from meiotic age-related errors, early DNA replication mistakes, and mitotic segregation problems—are a major root cause of IVF cycle failure and a contributor to some birth defects. Modern tools (PGT-A, improved lab practice, careful counseling) reduce risk but do not eliminate the fundamental biological challenge. Continued research aims to better predict, prevent, or manage these errors so more IVF embryos develop into healthy babies.